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Abstract Oxidative damage to the inner ear is responsible for
several types of sensorineural deafness. Cochlear stria marginal
cells (MCs) are thought to be vulnerable to such oxidative
stress. Activated poly(ADP-ribose) polymerase 1 (PARP1)
has been implicated in several diseases, but the effect of PARP1
on MCs subjected to oxidative stress remains elusive. In this
study, we established an in vitro cellular oxidative stress model
using glucose oxidase (GO) and attempted to explore the role
that PARP1 plays in the oxidative damage of MCs. In this
study, PARP1 and poly-ADP-ribose (PAR) were highly
expressed in GO-treated MCs, and this was accompanied by
loss of MC viability, excessive generation of reactive oxygen
species (ROS), collapse of mitochondria membrane potential
(ΔΨm), and redistribution of the mitochondrial downstream
pathway-related molecules Bax and cytochrome c, eventually
causing MC death. These effects were almost completely
counteracted by suppressing PARP1 expression with small
interfering RNA (siRNA). We also found that caspase-3 activa-
tion was a downstream event of PARP activation and that apo-
ptosis of MCs was suppressed, although not completely, by
pretreatment with the pan-caspase inhibitor z-VAD-fmk. The
suppression was less than that when PARP1 expression was
inhibited. We conclude that GO treatment induces activation
of PARP1, which causes MC damage via mitochondrial medi-
ation. PARP1 plays a pivotal role in GO-induced MC death, at
least in part, via the caspase-3 cascade. Our studymight provide
a new cellular and molecular approach for the treatment of
oxidative stress-related sensorineural deafness.
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Introduction
Oxidative damage to the inner ear is responsible for several
types of sensorineural hearing loss, including presbycusis, he-
reditary deafness, noise deafness, and toxicity deafness. The
damage causes reduced endocochlear potential (EP), inner ear
reactive oxygen species (ROS) accumulation, and cell apopto-
sis, all of which eventually result in structural changes and
functional impairment [1–3]. ROS derived from hydrogen
peroxide (H2O2), superoxide (O2), and peroxynitrite
(ONOO) are highly reactive and can lead to cell injury [4].
Glucose oxidase (GO) is a steady H2O2 generator; at a
concentration of 10mU/ml, it can generate H2O2 continuously
at a rate of 1.0–2.4 μM/min for up to 24 h in the presence of
5 mM glucose [5]. Because glucose oxidase catalyzes the
oxidation of D-glucose in vitro, high glucose concentrations
generate ROS as a result of glucose auto-oxidation. Chang
found that glucose oxidase and exogenous H2O2 have similar
biological effects in that both induced apoptosis in HepG2
cells in vitro [5]. Based on these findings, GO was used to
induce oxidative stress in our research.
It is well known that mitochondrial DNA (mtDNA) is a
biologically important source of adenosine triphosphate
(ATP) and that it is located in the vicinity of the respiratory
chain, the main site where endogenous ROS are produced.
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Thus, elevated ROS can damage mitochondrial DNA, which
may lead to severe consequences, including impairment of the
respiratory chain and decreased ATP synthesis, collapse of
mitochondrial membrane potential (ΔΨm), and even cell ap-
optosis [5, 6]. Because stria marginal cells (MCs) harbormuch
more mitochondria than other cells in the cochlea, they are
particularly vulnerable to ROS attack [7]. Furthermore, MCs
are believed to be extremely sensitive to oxidative damage
caused by senility and noise [8, 9]. However, the molecular
mechanism of oxidative stress-induced apoptosis in marginal
cells is not very clear. A better understanding of the cellular
and molecular mechanisms associated with oxidative stress-
related strial marginal cell degeneration and declines in regen-
erative capacity is required to identify and explore potential
interventional strategies for the prevention and treatment of
oxidative stress-related hearing loss.
Poly(ADP-ribose) polymerase 1 (PARP1), a post-
translational modification enzyme found mainly in the nucle-
us but also in a few extranuclear sites of most eukaryotic cells,
is called the genome guardian [10]. PARP could be activated
when mtDNA is damaged [11], and it catalyzes the hydrolysis
of NAD+ into nicotinamide and ADP-ribose, the latter of
which is used to synthesize poly-ADP-ribose (PAR) [12],
the activated form of PARP1 [13–16]. To prevent excessive
NAD+ consumption and energy exhaustion, PARP is specif-
ically disassembled into 24- and 89-kDa fragments by activat-
ed caspase-3, and the cells then enter the classic caspase-
dependent apoptosis process [17, 18]. The fragments of
PARP1 resulting from degradation by caspases are seen as
an indicator of apoptosis [19, 20]. However, overactivated
PARP1 could eventually lead to the exhaustion of cellular
NAD and ATP and cell necrosis [21]. Thus, PARP1 is a key
mediator of cell death.
Activated PARP1 has been implicated in several disease
models [22–25]. However, the effect of PARP1 on marginal
cells subjected to oxidative damage remains elusive. In this
study, a PARP1 small interfering RNA (siRNA)-specific ade-
noviral vector was employed to examine the role that PARP1
plays in the GO-induced oxidative damage of MCs.
Materials and Methods
Culture and Identification of Rat MCs
MCs were primarily cultured following the procedures
established by our laboratory [26]. Cytokeratin-18 (CK18), a
previously established marker of MCs [27, 28], was detected
by immunofluorescence. MCs were seeded onto coverslips
precoated with poly-L-lysine (Sigma-Aldrich, St. Louis, MO,
USA). After the cells fused to form a monolayer, the culture
medium was discarded. Then, the samples were washed in
cold phosphate-buffered saline (PBS) and fixed with 4 %
formalin for 15 min at room temperature. After three more
washes with PBS, MCs were permeabilized in 0.3 % Triton
TM X-100 (Sigma-Aldrich, St. Louis, MO, USA) for 20 min
and thenwashed three times with PBS. The cells were blocked
for 10 min with a 5 % bovine serum albumin (BSA) and then
incubated overnight at 4 °C with a primary antibody against
CK18 (1:50, Abcam, Cambridge, MA, USA). The following
day, the cells were stained with anti-rabbit IgG (1:100) for
30 min at room temperature and then washed three times with
PBS. The cells were washed and stained with 4′,6-diamidino-
2-phenylindole (DAPI, Sigma-Aldrich, St. Louis, MO, USA)
at room temperature for 3 min to identify the nuclei. After-
ward, the slides were mounted and visualized under a fluores-
cence electron microscope.
GO Exposure
We measured cellular activity by detecting formazan trans-
formed from WST-8 in active cells using a cell counting kit
(CCK-8/WST-8, Dojindo Laboratories, Kumamoto, Japan).
Briefly, cells were resuspended once the MCs fused to form
a monolayer. The MCs were then seeded into 96-well plates,
allowed to adhere to the plate, and then treated with different
concentrations of GO for 24 h. Each concentration was tested
in triplicate. Then, 20μl of a CCK-8 test solution was added to
each well, with 0 mU/ml GO serving as the control group and
wells without cells serving as blanks. The absorbance was
determined at 450 nm after incubation for 1.5 h at 37 °C. In
the CCK-8 assay, methyl thiazolyl tetrazolium WST-8 is
cleaved to soluble formazan by active cells, and the corre-
sponding optical density (OD) value is indicative of the cellular
activities of MCs. The activity of cells ×%=(ODexperimental−
ODmedium blank)/(ODcontrol−ODmedium blank)×100 %.
Transfection of MCs with Adenovirus
OnceMCs fused to form amonolayer, they were culturedwith
EpiCM-animal medium containing the Ad-PARP1-RNAi re-
combinant virus (GeneChem, Shanghai, China) for 4 h. After-
ward, the MCs were treated with 20 mU/ml GO for 24 h and
then harvested. As a mock-infected group, MCs were also
infected with non-specific siRNA. Infection efficiency was
assessed in terms of PARP1 expression as measured by re-
verse transcription-polymerase chain reaction (RT-PCR) and
western blotting (described below).
Grouping
MCs were randomly divided into six groups: (1) control (un-
treated MCs), (2) GO (MCs were treated with 20 mU/ml GO
for 24 h), (3) GO+ Ad-PARP1-RNAi (after infection with Ad-
PARP1-RNAi, MCs were treated with 20 mU/ml GO for
24 h), (4) GO+mock (after infection with Ad-mock-RNAi,
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MCs were treated with 20 mU/ml GO for 24 h), (5) GO+z-
VAD-fmk (after treatment with 50 μmol/l z-VAD-fmk for
30 min, MCs were treated with 20 mU/ml GO for 24 h), and
(6) z-VAD-fmk (MCs treated with 50 μmol/l z-VAD-fmk for
30 min).
Evaluation of Apoptosis by Flow Cytometry and DAPI
Nuclear Staining
Annexin V-FITC/propidium iodide (PI) double labeling was
used to evaluate the rate of MC apoptosis. Briefly, after each
treatment, cells were rinsed twice with cold PBS and incubat-
ed with trypsin until 80 % of the cells were detached. Cell
suspensions were collected and centrifuged at 1000 rpm for
5 min. The supernatant was discarded, and cold PBS was used
to wash the pellets two times. The cells (1×105) were resus-
pended in 100 μl of 1× binding buffer containing 5 μl annexin
V-FITC and 10 μl PI, incubated for 15 min at room tempera-
ture in the dark, and then (BD Biosciences, Carlsbad, CA)
analyzed by flow cytometry. After DAPI nuclear staining (as
described below), the cells were monitored under a fluores-
cence microscope for nuclear change.
Detection of Intracellular ROS Content and Distribution
by Flow Cytometry and Laser Confocal Microscopy
The intracellular ROS level was detected using DCFH-
DA (Beyotime, Shanghai, China), an oxidation-sensitive
fluorescence probe. Cells were seeded into six-well
plates (1×105 cells/well) and treated in terms of group-
ing (Fig. 4) for the indicated amount of time. They
were then cultured with DCFH-DA (10 μM) for
30 min at room temperature and examined by flow cy-
tometry. The distribution of ROS was detected by co-
culturing cells with MitoTracker Red CMXRos (a
mitochondria-selective dye; Invitrogen, Carlsbad, CA,
USA) and DCFH-DA and then visualizing them by
fluorescence microscopy.
Determination of ΔΨm was performed using a multifunc-
tional microplate reader and fluorescence microscopy. Chang-
es in ΔΨm were detected using the Mito-ID membrane po-
tential cytotoxicity kit (ENZO Life Sciences, NY, USA) ac-
cording to the manufacturer’s instructions. Briefly, after treat-
ment, the cells in each group were loaded with MitoTracker at
37 °C for 30 min. The fluorescence signal (Ex=485 nm/Em=
590 nm) of ΔΨm was read on a plate reader (BioTek® Syn-
ergy 2 Multi-Mode microplate reader, USA) and visualized
under a fluorescence microscope.
Immunofluorescence and Confocal Microscopy
We detected the distribution of PARP1, cytochrome c, and
Bax in the MCs by immunofluorescence and confocal
microscopy (LSCM, Nikon, Tokyo, Japan). MCs were first
seeded onto polylysine-treated coverslips. After the cells fused
to form a monolayer, they were treated with 300 nM
MitoTracker and then incubated at 37 °C for 45 min. After-
ward, the cells were stained with primary antibodies overnight
at 4 °C (anti-PARP1 1:50, anti-Bax 1:25, Santa Cruz, CA,
USA; anti-CytC 1:100, Invitrogen, Carlsbad, CA, USA). Af-
ter the specimens were incubated with the corresponding sec-
ondary fluorescent antibodies for 30 min, the nuclei were la-
beled with DAPI for 3 min at room temperature. The MCs
were then mounted and observed under an LSCM. The laser
beam was set at 488 nm for the FITC-conjugated antibody, at
555 nm for MitoTracker, and at 405 nm for DAPI. Images
were acquired simultaneously in the green, red, and blue chan-
nels. Images were imported into the Corel Draw X5 software
package (Corel, Canada), and the images of representative
cells from each well were recorded.
Measurement of Cytochrome C and Bax
in the Mitochondrial/Cytosol
A mitochondria/cytosol isolation kit was used to separate the
mitochondria and cytosol of MCs according to the manufac-
turer’s protocol (BioVision, San Francisco, USA). After treat-
ment with GO (20 μM/ml, 24 h) or pretreatment with Adr for
24 h, cells (5.0×107) were collected and suspended in 1 ml of
isolation buffer containing protease inhibitors and lysed on ice
for 10 min. After mechanical homogenization with a Dunce
grinder, a mixture containing unbroken cells, debris, and nu-
clei was separated by centrifugation at 800×g for 10 min at
4 °C. The supernatants were centrifuged at 10,000×g for
30 min at 4 °C to obtain the cytosolic fraction (supernatant).
The pellets were resuspended in 100 μl Mitochondrial Extrac-
tion Buffer Mix containing DTT and protease inhibitors,
vortexed for 10 s, and then saved as the mitochondrial frac-
tion. The mitochondria and cytosol were used for detection of
cytochrome c and Bax by western blotting.
Determination of Caspase-3 Activity
Because activated caspase-3 plays a critical role in the
final classical pathway in caspase-dependent apoptosis,
the activity of caspase-3 was determined using a chemical
self-illumination technique that employs Ac-DEVD-AFC
(ENZO Life Sciences, USA), a specific fluorogenic sub-
strate for caspase-3. The activity of caspase-3 was deter-
mined on a multifunctional microplate reader equipped
with a 400-nm excitation filter and a 505-nm emission
filter. All assays were carried out in triplicate, and the
results were expressed as fold change relative to the con-
trol group.
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Western Blotting
MCs seeded in six-well plates (3.0×105/well) were pretreated
with a virus for 48 h and then treated with GO (20mU/ml, 24 h).
The cells were harvested and homogenized in RIPA lysis buffer
(Beyot ime, Shanghai , China) conta in ing 1 mM
phenylmethylsulfonyl fluoride. The homogenate was centri-
fuged and the supernatant was collected. Protein concentration
was determined using a BCA kit. Cell lysates were subjected to
12 % SDS-polyacrylamide gel electrophoresis (PAGE), follow-
ed by protein transfer to a PVDFmembrane and incubation with
anti-PARP1, anti-Bax (Santa Cruz, CA, USA), anti-PAR
(ENZO Life Sciences, USA), anti-CytC (Invitrogen, CA,
USA), anti-cleaved caspase-3 (Abcam, Cambridge, UK), and
β-actin (Cell Signaling Technology, MA, USA) antibodies. Im-
munoblots were probed with horseradish peroxidase-conjugated
secondary antibodies and visualized using an enhanced chemi-
luminescent reagent (Millipore, MA, USA). The band intensity
was determined by densitometry using a ChemiDoc XRS (Bio-
Rad, USA) and normalized to β-actin. The change in protein
levels was expressed relative to the control.
RNA Isolation and Real-Time PCR
Following treatment, messenger ribonucleic acid (mRNA) was
isolated from rat MCs using Trizol® reagent (Invitrogen, Carls-
bad, CA, USA) according to the manufacturer’s instructions.
RNA concentration was measured in terms of the OD260/280
ratio. mRNA was reverse transcribed into complementary de-
oxyribonucleic acid (cDNA) using a high-capacity cDNA re-
verse transcription kit (Applied Biosystems, CA, USA). Real-
time PCRwas performed in a final volume of 10μl using Power
SYBR Green PCR Master Mix reagents (Applied Biosystems,
CA, USA) and run on an ABI Prism 7300 Real-Time PCR
System (Applied Biosystems, CA, USA). Each sample was an-
alyzed in triplicate, and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH)was used as an internal control. The primer pairs
used for PARP1 and GAPDHwere as follows: PARP1 forward,
5′-GAGTGGGCACAGTT-ATCGGC-3′; PARP1 reverse, 5′-
CCAGGC ATTTCCAGTCTTCTCT-3′; GAPDH forward, 5′-
TT CAACGGCACAGT CAAGG-3′; PARP1 reverse, 5′-
CTCAGCACCAGCATCACC-3′. The amplification conditions
were as follows: 95 °C for 30 s, followed by 40 cycles of dena-
turation at 95 °C for 30 s, annealing at 60 °C for 60 s, and
extension at 95 °C for 5 s. Changes in mRNA levels were
corrected against GAPDH using the 2-ΔΔCT method.
Statistical Analysis
The results were expressed as the mean±SEM of the three
measurements. The statistical analyses were conducted using
the SPSS 19.0 software package (IBM, USA). One-way
ANOVA and a two-tailed independent-sample t test were used
for the evaluation of the differences between the treatment and
control groups. Differences with a P≤0.05 were considered to
be significant. The western blotting images were quantitative-
ly assessed by employing ImageJ software (NIH, USA). The
chi-square test was used to assess the variation in apoptosis
rates between groups, and the corrected P value (P′=P/[k(k−
1)/2]t1) was employed for multiple comparisons.
Results
Primary Culture and Identification of MCs
Figure 1 shows that the MCs present a pleomorphic growth
pattern, with a clear boundary. MCs were closely connected
and grew into a monolayer, assuming a Bcobblestone-like^
appearance. Fluorescent signals indicative of CK18 (a bio-
marker of the epithelium) were strong in the cultured cells.
Expression of PARP1 in MCs
As shown in Fig. 2a, PARP1 was mainly expressed in nuclei,
and a few signals overlapped with the fluorescence of mito-
chondria. RT-PCR and western blotting showed that after
MCs were infected with the Ad-PARP1-RNAi recombinant
adenoviruses, PARP1 expression was dramatically decreased
at both the mRNA and protein levels when compared to the
control and mock-infected groups (Fig. 2b, c).
Effect of GO Treatment on MC Viability and PARP1
Activity
Figure 3a shows that treatment with a lower concentration of
GO slightly increased the viability of MCs, although the in-
crease was not statistically significant. In contrast, GO con-
centrations over 10 mU/ml induced a statistically significant
loss of viability in a concentration-dependent manner. We de-
duced that the concentration of GO required to induce oxida-
tive damage in MCs was 20 mU/ml and that this results in a
considerable reduction in viability compared to the 0 mU/ml
treatment group (P<0.05).
Western blotting revealed that, after treatment with 20 mU/
ml GO for 24 h, PAR and PARP1 cleavage proteins (85 kDa)
were significantly upregulated compared to the control group
(Fig. 3b) (P<0.01). In contrast, infection with the Ad-PARP1-
RNAi virus before GO treatment downregulated the expres-
sion (P<0.01).
ROS Generation in MCs
The ROS accumulation and distribution in MCs were ob-
served by flow cytometry and fluorescence microscopy, re-
spectively. The results showed that exposure of MCs to
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20 mU/ml GO for 24 h increased ROS generation approxi-
mately fourfold compared to the control group (Fig. 4a, b;
P<0.01). The ROS production of the GO+Ad-PARP1-RNAi
group was significantly reduced compared to the GO group
(P<0.01). However, the GO+mock group did not exhibit any
change in ROS generation when compared to the GO group
(P>0.05). Figure 4c shows that most of the DCFH-DA signals
(green florescence) overlapped with the MitoTracker signals
(red florescence). These findings suggested that the mitochon-
dria were primarily responsible for the generation of ROS,
rendering MCs sensitive to oxidative damage and that inhibi-
tion of PARP1 could counteract the GO-induced increase of
intracellular ROS.
MC Death from Exposure to GO
Figure 5a, b shows that exposure of MCs to 20 mU/ml GO for
24 h resulted in a significantly increased rate of apoptosis
compared to the control group (P<0.01). However, MCs in
the GO+mock group did not exhibit any change in the rate of
apoptosis compared to the GO group (P>0.05).
DAPI staining revealed that, after exposure to GO for 24 h,
the nuclei of the MCs were condensed and fragmented, sug-
gesting that the cells were apoptotic. Fluorescence microscopy
showed similar results. In the cells in the GO+Ad-PARP1-
RNAi group, the characteristic apoptotic changes in the nuclei
were much less pronounced (Fig. 5c). The findings were con-
sistent with the results of FACS.
PARP1-Modulated MC Death
To assess mitochondrial damage in MCs after exposure to
GO, we measured ΔΨm in MCs by fluorescence detec-
tion using a microplate reader and under a microscope.
Concomitant with the increase in mitochondrial ROS
levels, MC ΔΨm sharply declined in the GO and GO+
mock groups compared to the control group (Fig. 6a;
P<0.01), and the ΔΨm increased significantly in the
GO+Ad-PARP1-RNAi group (P < 0.01). Under a
fluorescence microscope, MCs in the GO and GO+mock
groups presented green fluorescence, which is indicative
of apoptotic cells. On the contrary, MCs in the GO+Ad-
PARP1-RNAi and control groups displayed a large
amount of orange fluorescence, which is indicative of
healthy cells (Fig. 6b). Data obtained from the fluores-
cence microplate reader showed similar results (Fig. 6a).
These findings suggested the PARP1 could modulate the
GO-induced apoptosis of MCs via mitochondria, but that
inhibition of PARP expression could protect mitochondria
from dysfunction.
Relocation of Bax and Cytochrome C
Western blotting and immunofluorescence were performed to
investigate the possible mechanism of MC death after ΔΨm
loss and to elucidate the role of PARP1 in the process.Western
blotting showed that the expression of Bax in the mitochon-
dria was increased in the GO group, and, as a result, Bax
protein levels were reduced in the cytosol compared to control
cells. Pretransfection with Ad-PARP1-RNAi could signifi-
cantly counteract this change (Fig. 7a; P<0.01). There was
no difference in protein relocation between the GO+mock
and GO groups (P>0.05). The relocation pattern of cyto-
chrome c in MCs was opposite to that of Bax (Fig. 7b).
Consistent with the results of western blotting, fluores-
cence microscopy showed that Bax (green fluorescence)
was located in the cytosol and separated from the
MitoTracker (red fluorescence) and that cytochrome c fully
overlapped with mitochondria in control cells, presenting
orange fluorescence (Fig. 7c, d). Conversely, Bax gradually
migrated into mitochondria after GO treatment and partially
overlapped with red MitoTracker, indicating they
colocalized in the mitochondria (Fig. 7c). Moreover, cyto-
chrome c was scattered in the cytosol (Fig. 7d). However,
preinfection with Ad-PARP1-RNAi could clearly counter-
act these changes. In the GO+mock group, no such changes
were observed.
Fig. 1 The morphology and identification of MCs. The cultured primary cells with clear boundaries present with a Bcobblestone-like^ appearance.
Immunofluorescence of CK18 (green) expressed in the cytoplasm; nuclei are stained blue
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Effect of z-VAD-fmk on the Death of MCs
Activation of the classic caspase-dependent pathway is the
core mechanism that leads to apoptotic cell death. Release of
cytochrome c from the mitochondria to the cytosol is essential
Fig. 2 The expression of PARP1 in MCs. a PARP1 produces green
fluorescence which was mainly found in the nuclei. A few extranuclear
PARP1 signals overlapped with the red fluorescence marking the
mitochondria. b, c The changes in PARP1 mRNA and protein
expression after cells were infected with Ad-PARP1-RNAi recombinant
virus or non-specific siRNA. The data are presented as the mean±SEMof
three separate experiments. **P<0.01 vs. the control group. Scale bar=
50 μm
Fig. 3 GO treatment induces PARP1 activation. The optimal
concentration of GO treatment as determined by the CCK8 test. The
control group was treated with 0 mU/ml GO. The cellular viability of
groups that were exposed to over 10 mU/ml GO was all less than that
of the control group, indicating that the growth of the MCs was sup-
pressed when the GO concentration was greater than 10 mU/ml and that
the appropriate concentration of GO was 20 mU/ml. b, c The relative
protein levels of PARP1 and PAR in each group. The levels of PAR
and PARP1 cleavage proteins (85 kDa) increased significantly in the
GO group compared to the control group (P<0.01), indicating that
PARP1 was activated in MCs exposed to 20 mU/ml GO for 24 h. All
of the Y axis values of the western blot assays represent the percentage of
protein expression relative to β-actin. The data are presented as the mean
±SEM of three separate experiments. *P<0.05 vs. the control group,
**P<0.01 vs. the control group, ##P<0.01 vs. the GO group
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for the induction of apoptosis [29]. The finding that inhibition
of PARP1 could prevent GO-induced cell death prompted us
to examine the correlation between caspase-3 activation and
activated PARP1.
Figure 8a shows that the amount of cleaved caspase-
3 was significantly higher in the GO group than in the
control group (P<0.01) and that caspase-3 cleavage was
significantly lower in the GO+Ad-PARP1-RNAi group
(P<0.01) compared to the GO group. This change in
the pattern of cleaved caspase-3 was similar to that ob-
served with PAR (Fig. 3b) which is an indicator of the
activity of PARP1.
We then pretreated MCs with 50 μmol/l z-VAD-fmk for
30 min before GO treatment and measured caspase-3 activity
using Ac-DEVD-AFC, a caspase-3-specific substrate.
Figure 8b shows that caspase-3 activity sharply increased in
the GO group compared to the control group (P<0.01), while
in both the GO+Ad-PARP1-RNAi and GO+z-VAD-fmk
groups, caspase-3 activity apparently decreased compared to
the GO group (P<0.01). There were no differences in
caspase-3 activity between the GO+mock and GO groups
(P>0.05). These findings indicated that caspase-3 was acti-
vated by GO treatment and that its activity could be abolished
by z-VAD-fmk or by inhibiting PARP1.
Fig. 4 Detection of intracellular
ROS levels. a, b The ROS
accumulation (green fluorescent
DCF) in MCs was measured
using a fluorescence spectrometer
(λex 490 nm, λem 515 nm) and
by flow cytometry and
fluorescence microscopy. c The
distribution of intracellular ROS
was detected by co-culturing the
cells with MitoTracker (red) and
DCFH-DA (green) and then
observing them under a
fluorescence microscope.
**P<0.01 vs. the control group,
##P<0.01 vs. the GO group. Data
are expressed as the mean+SEM
(n=3). Scale bar=50 μm
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Western blotting showed that the levels of both cleaved
caspase-3 and cleaved PARP1 were reduced in the GO+z-
VAD-fmk group compared to the GO group (Fig. 8c;
P<0.05) but that full-length PARP1 was not inhibited.
Flow cytometry revealed that the apoptosis of MCs was
decreased to some extent in the GO+z-VAD-fmk group com-
pared to the GO group (Fig. 8d; P<0.05). However, the rate of
MC apoptosis in the GO+z-VAD-fmk group (34.77 %) was
higher than that (17.4 %) in the GO+Ad-PARP1-RNAi group
(Fig. 5a).
Discussion
Maintenance of endocochlear potential is essential for normal
hearing and depends primarily on the pumping mechanism of
the marginal cells of the cochlear lateral wall. Awide array of
pathological and physiological changes induced by aging,
stress, ischemia, noise, and ototoxic agents can cause irrevers-
ible damage to marginal cells, leading to excessive generation
of ROS and eventually to auditory impairment. PARP1, a
molecular sensor of DNA damage [30], is activated when
Fig. 5 Detection of cell
apoptosis. a, b The rate of
apoptosis was determined by flow
cytometry after annexin V-APC/
PI staining. The lower left
quadrants contain the viable cells
(AV−/PI−), the lower right
quadrants contain the early
apoptotic cells (AV+/PI−), the
upper right quadrants contain the
late apoptotic cells (AV+/PI+),
and the upper left quadrants
contain the necrotic cells (AV−/
PI+). c The morphology of MC
nuclei was visualized by
fluorescence microscopy after
DAPI staining. Untreated MCs
remained morphologically
normal. Typical apoptotic
changes such as nuclear
condensation (white arrows) and
nuclear fragmentation (red
arrows) were observed in the GO
group and in the GO+mock
group. **P<0.01 vs. the control
group, ##P<0.01 vs. the GO
group. Data are expressed as
the mean+SEM (n=3).
Scale bar=50 μm
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DNA is damaged and is thought to play a role in a variety of
diseases, such as diabetes [6, 22], arthritis [23], Parkinson’s
and Alzheimer’s diseases, cerebral ischemia, traumatic brain
injury [24], and somemalignancies such as ovarian carcinoma
[25]. Regarding the inner ear, most studies about the effect of
PARP1 have been conducted in the outer hair cells and a few
have been carried out in spiral ganglion neurons. In fact, little
research effort has been directed at the role of PARP1 inMCs.
However, at present, the role that PARP1 plays in different
inner cells remains controversial. Shi [31] demonstrated that
PARP1 was activated in some marginal cells and in some
vessels of the spiral ligaments and that activated PARP1 could
stimulate the expression of P-selectin and platelet-endothelial
cell-adhesion molecule-1 in the vessels of the spiral ligament
after exposure to loud noise, thereby triggering inflammatory
events. Although Jiang [32] found that PARP1 was decreased
in a mouse model of progressive kanamycin-induced hair cell
loss, they failed to detect the 89-kDa PARP1 fragment derived
from caspase and markers of classic apoptotic pathways (cy-
tochrome c, caspase-9, caspase-3, JNK, and TUNEL). Thus,
the role of PARP1 in the oxidative damage of MCs remains
poorly understood. In this study, we established an in vitro
cellular oxidative stress model using GO and attempted to
explore the role that PARP1 plays in the oxidative damage
of MCs.
In this study, the treatment of MCs with 20 μM/ml GO
induced an apparent loss of cell viability. Meanwhile, PARP1
expression and activity were significantly enhanced in the
GO-treated group compared to the control group (Fig. 3;
P<0.01), as was ROS generation and MC apoptosis (Figs. 4
and 5; P<0.01). DAPI staining also revealed typical apoptotic
changes, such as nuclear shrinkage and fragmentation. PARP1
activity was counteracted by preinfection with Ad-PARP1-
RNAi, and this was accompanied by the downregulation of
ROS generation and MC apoptosis. These results suggest that
ROS generation andMCdeath could be regulated by activated
PARP1 and raise the question as to how PARP1 regulates the
death of MCs.
Excessive ROS generation is generally followed by three
changes that lead to cell apoptosis: depolarization of the inner
mitochondrial membrane, release of Bcl-2 family proteins
from the mitochondria, and the opening of the permeability
transition pore (PTP) [33–35]. Of these, loss of mitochondrial
membrane potential (ΔΨm) is believed to be a crucial factor
in the apoptotic pathway. In most cells, excessive ROS are
produced by the mitochondria, which are easy targets of
Fig. 6 PARP1 RNAi ameliorates
the loss of mitochondrial
membrane potential. Changes in
ΔΨm between groups of MCs
were detected using a
multifunctional microplate reader
(a) and a fluorescence microscope
(b). a The fluorescence signals
(Ex=485 nm/Em=590 nm) of
ΔΨm in MCs were monitored on
a multifunctional microplate
reader after they were loaded with
MitoTracker. b Upon analysis by
fluorescence microscopy, the
healthy cells present orange
florescence (white arrows), and
the cells with a decreased ΔΨm
emitted only green fluorescence
(red arrows). Data are expressed
as the mean+SEM (n=3).
**P<0.01 vs. the control group,
##P<0.01 vs. the GO group.
Scale bar=50 μm
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ROS attack [36]. This study showed that the intense green
DCFH-DA signals overlapped with the red MitoTracker sig-
nals in GO-treated MCs, suggesting that GO could induce
excessive ROS generation and that mitochondria are respon-
sible for the local generation of most ROS. Additionally,
LSCM and western blotting showed that, in GO-treated
MCs, the decrease in ΔΨm was accompanied by the recruit-
ment of Bax from the cytosol to the mitochondria and that this
was followed by relocation of cytochrome c from the mito-
chondria to the cytosol. Furthermore, decreased PARP1 pro-
tein levels inhibited the relocation of a series of death-
associated proteins and prevented the death ofMCs. Our study
suggested that strong PARP activation might transmit a death
signal to the mitochondria, thereby causing depolarization of
the mitochondrial transmembrane potential and the relocation
of Bax, a member of the anti-apoptotic protein family, leading
Fig. 7 Relocation of Bax and CytC. a, b Western blot analysis showed
the relative expression of Bax and cytochrome c in the mitochondria and
cytoplasm, respectively. c, d The immunofluorescence of Bax,
cytochrome c, and MitoTracker and their subcellular distribution during
the GO-induced apoptosis of MCs were detected simultaneously by
confocal microscopy. Green fluorescence represents Bax and
cytochrome c and red fluorescence is indicative of MitoTracker. White
arrows show the distribution of Bax and cytochrome c in the control and
GO+Ad-PARP1RNAi group cells (c, d). Red arrows indicate the
redistribution of Bax and cytochrome c in the GO and GO+mock group
cells. The results are given as the mean of three separate experiments.
Scale bar=50 μm
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to the opening of high-permeability pores and the release of
cytochrome c from the mitochondria to the cytoplasm. Our
results demonstrated that PARP1 activation could trigger and
regulate MC death via a mitochondria-mediated pathway.
Our findings raise the question as to how PARP1 siRNA
downregulates ROS generation in MCs and protects mito-
chondria from oxidative damage. Previous reports showed
that oxidant-induced functional changes in the mitochondria
Fig. 8 PARP1-inducedMC death is partly caspase-dependent. aWestern
blot analysis showed the relative expression of cleaved caspase-3 in each
group. b The activity of caspase-3 following treatment of each group was
measured using a multifunctional microplate reader. c The change in the
amounts of cleaved caspase-3 and PARP1 expression in MCs was
detected by western blotting. d Differences in the rate of MC apoptosis
were determined by flow cytometry after annexin V-APC/PI staining.
Data are expressed as the mean+SEM (n=3). **P<0.01 vs. the control
group, #P<0.05 vs. the GO group, ##P<0.01 vs. the GO group
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are related to PARP1 activation rather than to the direct effect
of the oxidant on the mitochondria [37]. A number of studies
have shown that the poly-ADP-ribosylation of nuclear pro-
teins is involved in DNA repair or transcriptional regulation
[7, 38]. Less is known about how PARP(s) work onmitochon-
drial proteins. Many studies have demonstrated that, in mito-
chondria, poly-ADP-ribosylation occurred [39–41], which
may be involved in mitochondrial function. Lai [42] believed
that mitochondrial PARP1 could ADP-ribosylate many mito-
chondrial proteins (VDAC1, mitofilin, cytochrome c reduc-
tase core protein, COX subunit Va, etc.) at the transcriptional
level, thereby resulting in the dysfunction of the respiratory
chain. The dysfunction of the respiratory chain could lead to
the generation of excessive ROS, which cannot be removed in
time, eventually causing functional impairment of the mito-
chondria [43]. We found that some PARP1 was localized to
the mitochondria (Fig. 2a), and this led us to believe that
mitochondrial PARP1 might be involved in the regulation of
mitochondria-mediated MC death induced by GO.
Activation of the caspase cascade is intimately correlated to
mitochondrial oxidative dysfunction. Once cytochrome c re-
leases from damaged mitochondria and enters the cytosol, the
caspase cascade will be activated. Cytochrome c plays a pri-
mary role in the formation of the apoptosome complex by
activating the binding of procaspase-9 to Apaf-1 [44]. The
complex then activates caspase-3, leading to cleavage of
PARP1 and caspase-dependent apoptosis [20, 45]. To further
clarify the presence of the classic apoptotic cascade in GO-
induced MC apoptosis and the relationship between PARP1
and caspase-3, we detected the cleavage of caspase-3, an in-
dicator of caspase-3 activity. The results indicated that PARP1
siRNA effectively prevented caspase-3 activation in MCs
compared to MCs treated with GO alone (Fig. 8a; P<0.01),
suggesting that caspase activation was a downstream event of
PARP activation.
To further understand whether the caspase-dependent path-
way was solely responsible for PARP-dependent apoptosis in
MCs, we pretreated the cells with the pan-caspase inhibitor z-
VAD-fmk before GO exposure. We found that the cleavage
and activity of caspase-3 were much lower in the z-VAD-fmk-
pretreated group than in the GO-treated group. In addition, the
z-VAD-fmk-pretreated cells showed a decrease in cleaved
PARP1, a product of full-length PARP1 cleavage. The study
illustrated that z-VAD-fmk effectively inhibited caspase-3 ac-
tivity and decreased the PARP1 cleavage fragments as op-
posed to full-length PARP1 in MCs. In agreement with these
results, flow cytometry showed that the apoptosis of MCs was
suppressed, although not completely, by z-VAD-fmk pretreat-
ment (Fig. 7c; P<0.05) and that the suppression was less than
when PARP1 expression was inhibited (Fig. 5a). We conclude
that the caspase-associated apoptotic pathway is not the sole
pathway implicated in PARP1-dependent MC death induced
by GO. There may be other mechanisms in addition to the
typical caspase-dependent pathway that function inMCs. This
notion is different from the conclusion drawn from a previous
study suggesting that z-VAD-fmk could completely block the
NGF/p75ngfr/ceramide-induced apoptosis of epithelial cells
and neurons in otocysts and the cochleovestibular ganglia
[46]. A more recent study found that z-VAD-fmk significantly
reduced the number of annexin V-positive renal cancer cells
and that this apoptosis was considered to be caspase-
dependent [47]. However, Jiang et al. failed to detect the
markers of classic apoptotic pathways (cytochrome c, cas-
pase-9, caspase-3, JNK, and TUNEL) in a mouse model of
progressive kanamycin-induced hair cell loss [32].
Based on our results, we concluded the following: (1)
Treatment of MCs with GO could mimic oxidative damage
to MCs and that GO could considerably suppress MC activity
and induce massive ROS generation and apoptosis in MCs.
(2) Mitochondria are responsible for the generation of most
local ROS in MCs and are vulnerable to ROS attack induced
by GO. (3) GO treatment induces the activation of PARP1,
leading to a decreasedΔΨm via mitochondrial mediation, and
facilitates the relocation of the molecules in the downstream
pathway. Mitochondrial PAR might take part in the regulation
of mitochondria-mediated MC death. (4) PARP1 plays a piv-
otal role in GO-induced MC death that is, at least in part, via
the caspase-3 pathway. (5) In addition to the caspase-
dependent pathway, there might be other apoptotic pathways
involved in PARP1-dependent GO-induced MC death.
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